Effect of Food and a Proton-Pump Inhibitor on the Absorption of Encorafenib: An In Vivo–In Vitro–In Silico Approach

[Image: see text] Encorafenib is a kinase inhibitor indicated for the treatment of patients with BRAF mutant melanoma and BRAF mutant metastatic colorectal cancer. To understand the effect of food and coadministration with a proton-pump inhibitor (PPI), in vitro, in vivo, and in silico data were gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Piscitelli, Joseph, Hens, Bart, Tomaszewska, Irena, Wollenberg, Lance, Litwiler, Kevin, McAllister, Mark, Reddy, Micaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155203/
https://www.ncbi.nlm.nih.gov/pubmed/37037186
http://dx.doi.org/10.1021/acs.molpharmaceut.3c00016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155203/
https://www.ncbi.nlm.nih.gov/pubmed/37037186
http://dx.doi.org/10.1021/acs.molpharmaceut.3c00016

Ejemplares similares